Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Haemonetics Corporation logo

Haemonetics Corporation

Sector: Healthcare   

Industry: Medical Instruments & Supplies

81.41
 
USD
  
-0.57
  
(-0.70%)
Optionable: Yes  Market Cap: 4,184 M  90-day average vol: 277,872

Previous close: 81.98  Open: 82.68  Bid: 78.82  Ask: 84.19
52 week range    
72.26   
   95.26
Peers   
TMO / 
SYK / 
BDX / 
CERS / 
BAX / 
PKI / 
JNJ / 
Last updated: Wednesday 29th November 2023
38
MarketXLS Rank
30
Value
30
Technical
55
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BAX

0.012943 B35.986.87

BDX

0.012972 B37269.27

CERS

1 B-15.35.22

JNJ

0.0247450 B22.1171.06

MDT

0.0245139 B29.8101.99

PKI

0.001522 B17.1182.49

SYK

0.011294 B47.6248.19

TMO

0.0017234 B27587.05
Financials

HAE Income Statement

Annual
Mar-14Mar-15Mar-16Mar-17Mar-18Mar-19Mar-20Mar-21Mar-22Mar-23
Amortization-29 M-64 M-64 M-58 M-8 M26 M33 M-56 M-42 M
Amortization of intangibles-29 M-33 M-37 M-32 M-33 M26 M33 M-57 M-42 M
Basic EPS total0.680.33-1.09-0.510.861.071.511.570.852.27
Basic weighted shares outstanding52 M52 M51 M52 M53 M52 M51 M51 M51 M51 M
Cost of sales470 M476 M503 M508 M-492 M-550 M504 M473 M488 M554 M
Depreciation-53 M-53 M-66 M-58 M-77 M-110 M-44 M-51 M
Depreciation unreconciled-86 M-90 M-89 M-109 M26 M33 M-98 M-93 M
DepreciationAndAmortization-53 M-86 M-90 M-89 M-109 M26 M33 M-98 M-93 M
Diluted EPS total0.670.32-1.09-0.510.851.041.481.550.842.24
Diluted weighted shares outstanding52 M52 M51 M52 M54 M53 M52 M51 M51 M51 M
GainOnSaleOfBusiness-289000.0184000.0330000.0
GainOnSaleOfPPE-10 M-382000.0
GainOnSaleOfSecurity8 M-73000.08 M33 M10 M382000.0
GeneralAndAdministrativeExpense-8 M-6 M-6 M-6 M-6 M
Gross operating profit468 M434 M406 M378 M412 M418 M-504 M-473 M-488 M615 M
ImpairmentOfCapitalAssets-1 M-16 M-75 M-4 M-21 M-51 M-8 M-8 M
Income before tax36 M31 M-53 M-27 M60 M74 M87 M73 M64 M141 M
Income restructuring and M&A-49 M-37 M-22 M-31 M-21 M-26 M-4 M-657000.0
Income taxes1 M14 M2 M-1 M14 M19 M11 M-7 M20 M26 M
InterestExpenseNonOperating-13 M-13 M-6 M-13 M
InterestExpenseOperating-9 M-8 M-8 M-8 M-13 M
MiscOtherSpecialCharges-10 M-9 M-9 M-8 M899 M958 M972 M854 M976 M1,154 M
Net income from total operations35 M17 M-56 M-26 M46 M55 M77 M79 M43 M115 M
NetIncomeCommonStockholders35 M17 M-56 M-26 M46 M55 M77 M79 M43 M115 M
NetIncomeContinuousOperations35 M17 M-56 M-26 M46 M55 M77 M79 M43 M115 M
NetNonOperatingInterestIncomeExpense400000.0200000.0300000.0300000.013 M14 M6 M13 M
NonRecurringOperationExpense-3 M-3 M-20 M-1 M-5 M
Operating income48 M43 M44 M39 M-848 M-884 M-843 M-812 M-922 M-1,013 M
Operating income before depreciation (EBITDA)111 M109 M36 M54 M141 M184 M158 M159 M224 M
OperatingExpense420 M391 M362 M339 M-356 M-334 M339 M340 M434 M459 M
Other income net12 M12 M97 M67 M-907 M-958 M-930 M-885 M-986 M-1,154 M
OtherGandA-8 M-6 M-6 M-6 M-6 M
OtherImpairmentOfCapitalAssets2 M5 M92 M59 M-2 M-21 M51 M1 M577000.0
OtherOperatingExpenses-55000.0-5 M-2 M-282000.0-8 M33 M47 M33 M
OtherWriteOff-478000.0-110000.0-166000.0
PromotionAndAdvertising-4 M-4 M-2 M-3 M-4 M-4 M-4 M-7 M
RentAndLandingFees-8 M-6 M-6 M-6 M-6 M
Research & development expense54 M54 M45 M38 M39 M36 M31 M33 M47 M50 M
ResearchExpense54 M54 M45 M38 M39 M36 M31 M33 M47 M50 M
RestructringAndMnAIncome-49 M-37 M-22 M-31 M-21 M-26 M-4 M-657000.0
SalariesAndWages-13 M-14 M-9 M-13 M-17 M-20 M-24 M-26 M
Selling Gen & administrative expense366 M337 M317 M302 M317 M298 M282 M274 M340 M377 M
SellingAndMarketingExpense366 M337 M317 M302 M317 M298 M282 M274 M340 M377 M
SellingExpense366 M337 M317 M302 M317 M298 M282 M274 M340 M377 M
Special income/charges49 M53 M97 M38 M45 M101 M14 M14 M
Total Income available for interest expense (EBIT)27 M23 M-53 M-35 M52 M74 M73 M58 M128 M
Total common shares outstanding52 M52 M51 M52 M52 M51 M50 M51 M51 M51 M
Total net income35 M17 M-56 M-26 M46 M55 M77 M79 M43 M115 M
Total ordinary shares51 M51 M51 M51 M51 M51 M51 M51 M51 M51 M
Total revenues939 M910 M909 M886 M904 M968 M870 M993 M1,169 M
TotalExpenses890 M867 M865 M847 M-848 M-884 M843 M813 M922 M1,013 M
TotalRevenue939 M910 M909 M886 M904 M968 M870 M993 M1,169 M
WriteDown-5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today